The Caveolin-1 connection to cell death and survival
Author
dc.contributor.author
Quest, Andrew F. G.
Author
dc.contributor.author
Lobos González, Lorena
Author
dc.contributor.author
Nuñez, S.
Author
dc.contributor.author
Sanhueza, C.
Author
dc.contributor.author
Fernández, J. G.
Author
dc.contributor.author
Aguirre, A.
Author
dc.contributor.author
Rodríguez, D.
Author
dc.contributor.author
Leyton, L.
Author
dc.contributor.author
Torres, V.
Admission date
dc.date.accessioned
2019-03-15T16:04:16Z
Available date
dc.date.available
2019-03-15T16:04:16Z
Publication date
dc.date.issued
2013
Cita de ítem
dc.identifier.citation
Current Molecular Medicine, Volumen 13, Issue 2, 2018, Pages 266-281
Identifier
dc.identifier.issn
15665240
Identifier
dc.identifier.issn
18755666
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165924
Abstract
dc.description.abstract
Caveolins are a family of membrane proteins required for the formation of small plasma membrane invaginations called caveolae that are implicated in cellular trafficking processes. In addition to this structural role, these scaffolding proteins modulate numerous intracellular signaling pathways; often via direct interaction with specific binding partners. Caveolin-1 is particularly well-studied in this respect and has been attributed a large variety of functions. Thus, Caveolin-1 also represents the best-characterized isoform of this family with respect to its participation in cancer. Rather strikingly, available evidence indicates that Caveolin-1 belongs to a select group of proteins that function, depending on the cellular settings, both as tumor suppressor and promoter of cellular traits commonly associated with enhanced malignant behavior, such as metastasis and multi-drug resistance. The mechanisms underlying such ambiguity in Caveolin-1 function constitute an area of great intere